Koshinski Asset Management
RMD icon

Koshinski Asset Management’s ResMed RMD Stock Holding History

Koshinski Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-193
Closed -$46.8K – 1686
2022
Q1 		$46.8K Sell
193
-2,231
-92% -$540K ﹤0.01% 1142
2021
Q4 		$631K Buy
2,424
+2,077
+599% +$539K 0.05% 355
2021
Q3 		$91.5K Buy
+347
New +$94.9K 0.01% 877

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Koshinski Asset Management's RMD Position: Q2 2022 in Review

Koshinski Asset Management sold out of ResMed (RMD) in Q2 2022, closing a stake of 193 shares — an estimated $46.8K sold.

Koshinski Asset Management first reported a position in RMD in Q3 2021 and held it in 3 quarters. The position peaked at $631K in Q4 2021. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • Koshinski Asset Management reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 193 ResMed shares in Q2 2022, an estimated $46.8K.
  • Koshinski Asset Management first reported a position in ResMed in Q3 2021 and held it in 3 quarters.
  • Koshinski Asset Management's ResMed position peaked at $631K in Q4 2021.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.